Join the club for FREE to access the whole archive and other member benefits.

State of play of single-cell sequencing technology


Key points from article :

Single-cell sequencing can tell how individual cells in a group behave.

This technology is used by many companies to develop personalised medicine.

Highly sensitive and has the ability to detect rare cell types from limited amounts of sample material.

Single-cell collection is tricky, data analysis is complex and the sequencing procedure is very costly.

Its potential for research, drug discovery, and diagnostics is huge, but need more investments.

Extreme personalised medicine realises there is no such thing as an average cell

Mentioned in this article:


Biotechnology company developing technology for gene sequencing.


Senior researcher working at Institut Curie.


Biotechnology company that develop medicines.


Partner at Third Rock Ventures and Chief Scientific Officer at Celsius Therapeutics.


Cancer research centre.


Personalised Medicine company